Nuvation Bio Inc

NUVBNYSE · USD
5.73USD0.00 (+0.35%)
1210

Nuvation Bio Inc (NUVB) Options Open Interest

NUVB options open interest is 20,595 contracts. The 2-week average daily volume is 583 contracts across the chain.

Read more

Monitoring NUVB open interest helps you see where real money is positioned on Nuvation Bio Inc's options and which strikes are attracting the most commitment from traders. Nuvation Bio Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor NUVB options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising NUVB options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Nuvation Bio Inc to settle.

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer.

The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where NUVB open interest is concentrated. Our scanner maps Nuvation Bio Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Nuvation Bio Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
7.500.050.100.0889%+0.13152,869
10.00—0.750.75313%+0.363562
5.000.751.100.9389%+0.772611
2.501.105.503.30232%+0.96060
12.50—0.750.75367%+0.33490
Puts
5.000.050.200.1375%-0.1970564
7.501.252.351.8079%-0.901039
2.50—0.050.05219%-0.03381
10.003.704.804.2593%-0.99060
12.506.107.506.80183%-0.93660

As of September 24, 2026

Follow the money

Track NUVB open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial